New Key Statistics Module, Z-Score and F-Score
OTCPK:CMRA Key Ratios
Market Cap $ M | 0.82 |
Enterprise Value $ M | -0.77 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.51 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 1.00 |
EPS (TTM) $ | -0.49 |
Beneish M-Score | -6.21 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.09 |
EV-to-EBITDA | 0.09 |
PEG | -- |
Shares Outstanding M | 30.74 |
Net Margin (%) | -901.00 |
Operating Margin % | -914.60 |
Pre-tax Margin (%) | -901.00 |
Quick Ratio | 0.90 |
Current Ratio | 0.90 |
ROA % (ttm) | -263.84 |
ROE % (ttm) | -- |
ROIC % (ttm) | -383.38 |
Dividend Yield % | -- |
Altman Z-Score | -28.04 |
CMRA Number of Guru Trades
CMRA Volume of Guru Trades
Gurus Latest Trades with OTCPK:CMRA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CMRA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Comera Life Sciences Holdings Inc Insider Transactions
No Available Data
News about OTCPK:CMRA
Total 0- 1